We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK: BLOCK GENERIC FLONASE UNTIL GUIDANCE IS ISSUED
GSK: BLOCK GENERIC FLONASE UNTIL GUIDANCE IS ISSUED
June 11, 2004
GlaxoSmithKline (GSK) filed a citizen petition with the FDA that is delaying final approval of a generic version of the company’s profitable allergy nasal spray drug Flonase, generic drug sources said.